Labat Africa Ltd (JSE:LAB) — Market Cap & Net Worth
Market Cap & Net Worth: Labat Africa Ltd (LAB)
Labat Africa Ltd (JSE:LAB) has a market capitalization of $2.19 Million (ZAC4.13 Billion) as of June 22, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #29874 globally and #214 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labat Africa Ltd's stock price ZAC2.00 by its total outstanding shares 2065108879 (2.07 Billion). Review Labat Africa Ltd (LAB) financial obligations to assess the company's total debt and financial obligations.
Labat Africa Ltd Market Cap History: 2015 to 2026
Labat Africa Ltd's market capitalization history from 2015 to 2026. Data shows change from $164.62 Million to $2.19 Million (-32.61% CAGR).
Labat Africa Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labat Africa Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Labat Africa Ltd's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.07x
Labat Africa Ltd's market cap is 0.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $30.73 Million | $14.31 Million | $8.40 Million | 2.15x | 3.66x |
| 2017 | $41.70 Million | $52.01 Million | $4.64 Million | 0.80x | 8.98x |
| 2018 | $42.80 Million | $73.35 Million | $12.58 Million | 0.58x | 3.40x |
| 2019 | $45.00 Million | $616.43 Million | -$72.94 Million | 0.07x | N/A |
| 2020 | $47.19 Million | $40.25 Million | $946.00K | 1.17x | 49.89x |
| 2021 | $31.83 Million | $29.27 Million | -$22.75 Million | 1.09x | N/A |
| 2022 | $10.97 Million | $30.72 Million | -$48.11 Million | 0.36x | N/A |
| 2023 | $7.68 Million | $49.53 Million | -$86.90 Million | 0.16x | N/A |
| 2024 | $7.68 Million | $48.54 Million | -$25.80 Million | 0.16x | N/A |
| 2025 | $8.78 Million | $199.40 Million | $117.87 Million | 0.04x | 0.07x |
Competitor Companies of LAB by Market Capitalization
Companies near Labat Africa Ltd in the global market cap rankings as of June 22, 2026.
Key companies related to Labat Africa Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #602 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #602 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.50 |
Labat Africa Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Labat Africa Ltd's market cap moved from $164.62 Million to $ 2.19 Million, with a yearly change of -32.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ZAC2.19 Million | -75.00% |
| 2025 | ZAC8.78 Million | +14.29% |
| 2024 | ZAC7.68 Million | 0.00% |
| 2023 | ZAC7.68 Million | -30.00% |
| 2022 | ZAC10.97 Million | -65.52% |
| 2021 | ZAC31.83 Million | -32.56% |
| 2020 | ZAC47.19 Million | +4.88% |
| 2019 | ZAC45.00 Million | +5.13% |
| 2018 | ZAC42.80 Million | +2.63% |
| 2017 | ZAC41.70 Million | +35.71% |
| 2016 | ZAC30.73 Million | -81.33% |
| 2015 | ZAC164.62 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Labat Africa Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.19 Million USD |
| MoneyControl | $2.19 Million USD |
| MarketWatch | $2.19 Million USD |
| marketcap.company | $2.19 Million USD |
| Reuters | $2.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Labat Africa Ltd
Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more